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Abstract
Irritable bowel syndrome (IBS) has been shown to be associated with psychological
symptoms as well as physical. Despite this correlation, physicians are more likely
to focus on and provide treatments primarily for the physical aspects of IBS, which
may result in a less-than-ideal treatment of the disorder. This literature review
examines many IBS-related studies which show the existence of psychological
components of IBS and the efficacy of treatment methods based in psychology.
The conclusion of this research is that the current medical treatments of IBS
are insufficient, and patients would likely see more improvements if physicians
were to create a more holistic, individualized treatment plan for each patient
by assessing for and treating the psychological aspects of IBS in addition to the
physical aspects.
Keywords: irritable bowel syndrome, individualized treatment, antidepressants,
psychotherapy, holistic treatment
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The Need for a More Holistic Approach for the Treatment of Irritable Bowel Syndrome
Irritable bowel syndrome (IBS) is a gastrointestinal disorder
characterized by periodic abdominal pain and abnormal bowel movements
which affects approximately 10–20% of adults in Western countries (Lovell &
Ford, 2012). Although the disorder is not life-threatening, it can have debilitating,
if not devastating, effects on the social, professional, and personal lives of those
who have it. Not only does IBS have encumbering physical symptoms and
social effects, but research has found psychological connections as well (TosicGolubovic et al., 2010). IBS is commonly comorbid with psychological disorders
such as depression and anxiety. Several studies have demonstrated the efficacy
of a holistic approach, incorporating psychological treatment as well as physical
treatment, in improving symptoms of IBS (Craske et al., 2011; Ljótsson et al.,
2014; Muscatello et al., 2010).
There is a need for improvement in the way people with IBS are diagnosed
and treated due to the evidence that physicians currently focus primarily on
the physical aspects of IBS, often leaving patients dissatisfied (Harvey et al.,
2018; Shivaji & Ford, 2015). Despite the benefits of holistic treatment methods,
evidence suggests that clinicians are more likely to use or recommend traditional
medicinal treatments, such as soluble fiber and antispasmodics, rather than
therapy or medication focused on the mental aspects of IBS (Shivaji & Ford,
2015). Additionally, many physicians view IBS simply as a diagnosis of exclusion;
this means that, rather than using the gastroenterologist-developed diagnostic
criteria to specifically address IBS, many physicians provide an IBS diagnosis only
after ruling out other gastrointestinal issues. Moreover, many who suffer from IBS
have expressed dissatisfaction in the process of seeking treatment, specifically
in a lack of individualized care shown by clinicians (Harvey et al., 2018). The
improvement of individual IBS patients may depend on the improvement of the
individualization of the IBS treatment process.
More personalized treatment would likely be more effective in treating IBS,
thus providing those who suffer from this disorder with more relief, freedom, and
a better life overall. Although most of the symptoms are physical, it would be
beneficial if clinicians were to go beyond diagnosing and treating only the physical
aspects of IBS by assessing and presenting a holistic treatment plan tailored to
the patient’s psychological needs as well. This kind of individualized diagnosis
and treatment is warranted for the following reasons: assessing for psychological
https://scholarsarchive.byu.edu/intuition/vol15/iss2/10
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issues may provide good indication for which treatments will be most beneficial
for the individual, psychopharmacological treatments have shown great potential
for alleviating IBS symptoms, and psychotherapeutic treatments can also have a
significant impact on both the physical and psychological aspects of IBS.

Methods
To find the articles included in this review, I searched the APA PsycInfo
database for the terms “irritable bowel syndrome or IBS” AND “mental illness”
AND “treatment.” I narrowed the search to peer reviewed articles from the years
2000–2020, which yielded 21 results. I also conducted a similar search with only
the terms “IBS” AND “mental illness,” and then I searched for “IBS” AND
“treatment.” After reading through the abstracts of these articles, I selected the
ones that were most relevant to the subject I was studying, which is the interaction
between mental illness and irritable bowel syndrome and the treatment methods
which take this interaction into account. Additionally, I found other sources
referenced within some of those articles which were also relevant to this review
and have thus included them.

The Value of Psychological Assessments in Diagnosing
and Treating IBS
To ensure that each patient receives an individualized, holistic, and therefore
more effective treatment plan, psychological assessments should be administered
to patients to evaluate their levels of predicting psychological factors as part
of the diagnostic process for IBS. Between all the different kinds of therapies,
medications, and other treatment options for patients with IBS, prescribing an
effective and feasible treatment plan is a complicated task for clinicians (Shivaji &
Ford, 2015). Studies have shown that the treatment option that will work best for
a certain person can often be predicted by psychological factors such as anxiety,
depression, trauma, alexithymia, and somatization (Creed et al., 2008; Farnam et
al., 2014; Mohamadi et al., 2019; Porcelli et al., 2017). To measure these factors,
simple (but reliable) questionnaires could be given to patients such as the Visceral
Sensitivity Index, Toronto Alexithymia Scale, Hospital Anxiety and Depression
Scale, Recent Physical Symptoms Questionnaire, and the Comorbid Medical
Conditions Questionnaire (Creed et al., 2008; MacLean et al., 2012; Muscatello
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et al., 2010; Porcelli et al., 2017). Paired with follow-up questions or interviews,
these tests would give physicians a more in-depth analysis of the psychological
components of the disorder rather than the physical components alone, allowing
them to identify the best treatment option for that specific patient.

Testing for Comorbid Mental Illnesses
Several studies done in recent years have shown patterns of comorbidity with
IBS and psychological disorders; that knowledge of an individual’s comorbidities
can lead to the implementation of effective treatment options (Cho et al., 2011;
Mohamadi et al., 2019; Muscatello et al., 2010). The psychological aspects of
IBS appear to be bidirectional, so whether IBS symptoms cause or are caused
by psychological issues like anxiety and depression, clinicians’ knowledge of
and treatment tailored to these specific characteristics in individuals will lead to
better quality treatment (Muscatello et al., 2010). A study conducted by TosicGolubovic et al. (2010) illustrated this by comparing the anxiety and depression
levels of IBS patients to both people experiencing a depressive episode and
healthy individuals. The levels of depression and anxiety in IBS patients were
significantly closer to the participants experiencing a depressive episode than
to those considered healthy. While not every person with IBS has high levels
of depression or anxiety, if physicians are knowledgeable about these issues,
they can help address them with the treatment that best fits each patient’s
individual experience. For example, in a study by Mohamadi et al. (2019),
positive psychotherapy was shown to improve levels of overall quality of life,
while mindfulness-based cognitive therapy (MBCT) was shown to lower levels of
perceived stress than the other therapies tested. By understanding this research
and assessing an individual patient’s needs, a physician can prescribe more
effective treatments catered to the individual—for example, prescribing MBCT
to patients with higher stress levels.
In addition to anxiety and depression, trauma is highly associated with IBS
and should therefore be assessed for and treated in IBS patients. One study found
that PTSD and IBS had a 23% comorbidity rate among Iraq and Afghanistan
veterans (Maguen et al., 2014). Mindfulness-based stress reduction has shown
potential as an efficacious treatment for veterans with IBS and PTSD (Harding
et al., 2018). In addition to being prevalent among veterans, IBS is also common
among victims of abuse (Creed et al., 2005). In a study of patients with severe
https://scholarsarchive.byu.edu/intuition/vol15/iss2/10
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IBS, Creed et al. found that victims of sexual abuse experienced significant
improvement in IBS symptoms after undergoing psychological treatment (either
psychotherapy or antidepressants), while those who received only the usual
treatment experienced little to no change. By screening IBS patients for PTSD
symptoms and signs of abuse, clinicians can recommend effective treatments,
especially psychological treatments like those previously discussed.

Testing for Alexithymia
Alexithymia, the inability to discern or express one’s own emotions, is
prevalent among the IBS population and can exacerbate IBS symptoms, which
makes assessing and being aware of the condition important for physicians
(Farnam et al., 2014). In fact, Farnam et al. reported that patients with IBS
had higher scores in all three measured areas of alexithymia compared to the
scores of a normal population when their participants completed the Toronto
Alexithymia Scale. These findings are consistent with the findings of Porcelli
et al. (2017), which also show that alexithymia is a significant predictor of IBS
symptom severity. More than just finding the rates of alexithymia among IBS
patients, Farnam et al. (2014) also found an effective treatment method for this
population: emotional awareness training. Simply by attending two 30-minute
group training sessions and recording their emotions every day, IBS patients
with high levels of alexithymia experienced noteworthy improvement over
the 12 weeks of the study; of the group who received only medical treatment,
36% reported a significant decrease in pain, while 54% of those who received
emotional awareness training experienced significantly less pain. Similar
percentages to these were reported for the decrease in frequency of pain as well.
These findings provide extremely valuable insights for physicians treating IBS:
it is important to assess for alexithymia, and if assessments show that a patient
has high alexithymia levels, emotional awareness training may become a critical
component of the treatment plan for that patient.

Testing for Somatization
Another factor that should be measured in IBS patients along with
psychological comorbidities and alexithymia is somatization, which is the
recurrent production of multiple bodily symptoms without a perceptible physical
Published by BYU ScholarsArchive, 2020
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source (MacLean et al., 2012). Van Tilburg et al. (2013) found somatization to be
one of the highest predictors of IBS severity in a study measuring the effects of
psychological factors on IBS. In 2008, Creed et al. conducted a study to examine
how somatization effects the efficacy of treatment for patients with severe
IBS. The study revealed that not only did patients with higher somatization
levels have more severe IBS, but they also responded much more positively to
psychological treatment than to the usual treatment and experienced more
dramatic improvement than the participants with lower somatization levels. This
study demonstrates the practicality of assessing somatization levels in addition
to levels of anxiety, depression, trauma, and alexithymia in IBS patients and
prescribing a treatment plan that goes beyond usual medical care to include
psychopharmacological and/or psychotherapeutic treatments.

The Effects of Psychopharmacological Treatments on
Physical and Psychological Aspects of IBS
Psychological medication is one promising method of treatment for
patients with IBS. Despite the common comorbidity of IBS and psychological
disorders such as depression and anxiety, few studies have been done to examine
the effects of psychopharmacological treatments such as selective serotonin
reuptake inhibitors (SSRI) and serotonin-norepinephrine reuptake inhibitors
(SNRI) on IBS. Those that have tested the impact of these drugs on IBS patients
have found positive results on both the physical and mental symptoms of IBS,
indicating the drugs’ potential value and the pressing need for more testing on
the subject (Kaplan et al., 2014; Kuiken et al., 2003; Vahedi et al., 2005). As
more studies show the benefits of psychopharmacological treatments, clinicians
can prescribe these medications as part of an individualized treatment plan for
their patients.
One SSRI that has shown potential in the treatment of IBS is paroxetine.
In a study conducted in 2002, Masand et al. compared the effects of paroxetine
on the IBS symptoms of 10 IBS patients with a comorbid anxiety disorder and
10 IBS patients without an anxiety comorbidity. Following 12 weeks of the SSRI
treatment, most participants in both groups reported improvement in severity
and frequency of pain, constipation, and diarrhea. Although there was greater
improvement reported in the anxiety group, the difference was not enough to
be considered statistically significant, meaning that both those with and those
https://scholarsarchive.byu.edu/intuition/vol15/iss2/10
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without an anxiety disorder benefited from the treatment almost equally. While
this study indicates promising benefits of paroxetine in treating IBS symptoms,
some limitations are the small sample size and the lack of a placebo group.
However, a different study conducted by Masand et al. in 2009 did compare
the effects of paroxetine and a placebo on patients with IBS with a much
larger sample size of 72 participants (36 in each group). Although this study
did not find a statistically significant difference in the pain levels reported by
both groups, it did find significantly more improvement in the paroxetine group
in other measured areas such as Clinical Global Impression-Improvement and
Clinical Global Impression-Severity. While additional research should be done,
the results of these studies do indicate that paroxetine is a treatment option worth
considering for patients with IBS.
SNRIs also have great potential as a medical intervention for IBS,
particularly the drug duloxetine. Kaplan et al. (2014) conducted a study to
examine the effects of duloxetine on the symptoms of IBS and generalized
anxiety disorder in patients who experience both conditions comorbidly. After
receiving 12 weeks of treatment, nine of the 11 participants who completed
the study showed significant improvements in areas such as anxiety levels, IBS
symptom severity, and overall quality of life as it relates to IBS. A similar study
was conducted by Brennan et al. in 2009 in which duloxetine was given to eight
IBS patients for 12 weeks. Despite the fact that none of the participants had
major depression, the antidepressant proved to be effective in lowering levels of
anxiety, pain, and severity of illness while increasing quality of life in participants.
Despite small sample sizes and other limitations which indicate the need for more
research, these studies demonstrate the potential benefits of medication designed
for psychological disorders on the mental and physical aspects of IBS, both for
those with comorbid mental illnesses and those without.

The Effects of Psychotherapeutic Treatments on Physical and Psychological Aspects of IBS
Psychotherapy is another effective non-traditional treatment method for
individuals with IBS. In an interview-based study conducted by Harvey et al.
(2018), more than 50% of participants with IBS reported a general aversion to
taking medications for IBS. Many patients believed that rather than treating the
underlying causes of their disorder, the medications simply masked their symptoms.
Published by BYU ScholarsArchive, 2020
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While IBS may not always be caused by psychological factors, the frequency of
comorbidity with psychiatric disorders suggests that psychotherapeutic methods
of treatment may be helpful in addressing the core origins of the disorder in
some patients, as opposed to using purely medical interventions. This is especially
true in the frequent cases in which traumatic experiences like war or abuse are
concurrent with IBS (Creed et al., 2005; Maguen et al., 2014). Perhaps because
of this common cooccurrence of mental illness and IBS, several different kinds
of therapies have proven to be successful in treating both the psychological and
physical symptoms of this disorder and should therefore be considered for the
personalized, holistic treatment of IBS.

Effective Psychotherapeutic Models
One therapeutic model shown to be especially efficacious for IBS is MBCT.
A study of women with IBS found that compared to a wait-list control group,
the group that took part in MBCT sessions specifically adapted for IBS reported
significant improvements in IBS symptom severity, levels of depression and
anxiety, and quality of life (Henrich et al., 2020). Another study measured and
compared the effects of different therapy techniques (dialectical behavior therapy,
MBCT, and positive psychotherapy) on the perceived stress and quality of life
of people with IBS (Mohamadi et al., 2019). While the results showed greater
improvements in each of the therapy groups than in the control group, it also
found that MBCT in particular was more effective than the other therapies in
lowering participants’ perceived stress levels. Due to its apparent positive impact
on somatic and psychological aspects of IBS, MBCT should be considered by
clinicians as a prospective treatment option for patients with IBS.
Exposure therapy, which involves intentionally putting the patient in anxiety
inducing situations, is another highly effective treatment for anxiety disorders and
has shown promise as part of a therapeutic treatment of IBS. Craske et al. (2011)
conducted a study to test the efficacy of a treatment which combined aspects of
cognitive-behavioral therapy (CBT) and exposure therapy. When compared with
a control group and a stress management group, the group that received the CBT
treatment featuring interoceptive exposure to visceral sensations (meaning the
strategic introduction of feared feelings within the internal organs) experienced
significantly better results in several categories, including IBS-related anxiety and
pain vigilance. A similar study was conducted by Ljótsson et al. (2014) which
https://scholarsarchive.byu.edu/intuition/vol15/iss2/10
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directly compared the effects of two internet-delivered CBT treatments, with the
only difference being that one treatment included systematic exposure to IBSrelated symptoms and experiences, while the other did not. The study found that
the group who experienced the systematic exposure had greater improvement in
IBS symptom severity than the group that received CBT alone. While CBT has
been shown to be an effective treatment, the addition of exposure therapy can
lead to even greater improvements in physical and psychological effects of IBS.

Alternative Options to Traditional Psychotherapy
While one argument against using psychotherapeutic treatment methods for
patients with IBS is the inaccessibility thereof for many people, there are several
potential alternatives to regularly meeting individually with a therapist which are
also helpful for treating IBS. For example, studies have shown that gut-focused
hypnotherapy (involving progressive relaxation and therapeutic suggestions
focused on improving IBS symptoms) can produce significant positive results in
improving physical and mental well-being in IBS patients, even when administered
by a medical nurse or over Skype rather than in person by a psychologist (Hasan et
al., 2019; Lövdahl et al., 2015). Another alternative psychotherapeutic treatment
option was tested by Hunt et al. (2015) in a study where participants with IBS
were given a CBT self-help workbook specifically for IBS. Despite a small sample
size and other limitations, the success found in those who did complete the study
is an indication that self-help workbooks based on IBS-focused psychotherapy
techniques may be viable components in the treatment of IBS. Therefore, even
in circumstances where traditional therapy may be impractical, clinicians do not
have to rule out psychotherapeutic treatment options.
Another option to make these therapeutic treatments more accessible
to the general public without losing the benefits of a trained therapist is
administering them in the form of group therapy sessions. Because of the
ability to accommodate more patients at a time, group therapy is generally less
expensive, which provides a more accessible option for patients with IBS seeking
psychotherapeutic treatment (Berens et al., 2018). Ljótsson et al. demonstrated
the effectiveness of group therapy in their 2010 study. The study involved 34
individuals with IBS who participated in 10 weeks of group therapy sessions
focused on exposure and mindfulness. The results indicated improvement in
levels of pain, bloating, anxiety, social functioning, and other variables. Although
Published by BYU ScholarsArchive, 2020
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this study had limitations such as the lack of a control group and small sample
size, its findings are supported by a study done by Berens et al. (2018). This study
measured the effects of group therapy designed specifically for patients with IBS
and found moderate success, indicating that group therapy is a suitable treatment
option. Due to the success found in these studies, clinicians can recommend
group therapy as a viable psychological treatment for individuals with IBS.

Conclusion
The main limitation of this literature review is a lack of recent studies
on this important subject. In order to more fully help IBS patients, more research
should be done on IBS treatments, specifically psychology-based treatments.
While there is a lot of evidence to back up the use of psychotherapy as a
treatment for IBS, more research is required to get a better picture of which
psychopharmacological treatments are effective and to what degree they are
effective (Henrich et al., 2020; Ljótsson et al., 2014). A study should also be
done comparing patients’ experiences with the current “traditional” (medicalfocused) method of treatment versus experiences with a clinician who provides
psychological questionnaires and then develops an individualized treatment
plan based on those results. This further research and implementation of the
principles discussed can make an incredible difference in the lives of thousands
of people who suffer from IBS.
IBS is a complex disorder with unique components for each patient,
making it necessary for patients to receive individualized treatment. Many
studies have demonstrated that IBS can be more than a physical illness and that
integrating psychopharmacological and psychotherapeutic interventions into a
holistic treatment plan can have great benefits for people with IBS (Craske et al.,
2011; Ljótsson et al., 2014; Muscatello et al., 2010). By assessing the psychological
aspects of each patient’s individual diagnosis, physicians can gain a better idea of
an effective treatment plan for that individual, potentially including medication
like antispasmodics or antidepressants and therapeutic treatments like MBCT.
This review provides an analysis of several treatment methods (specifically
those with foundations in psychology) in order to illustrate that integration of
psychological and physical treatments into a more holistic approach is a viable
way to combat the lack of individualization. In addition to being valuable for
physicians treating IBS, these findings are also important for patients who suffer
https://scholarsarchive.byu.edu/intuition/vol15/iss2/10
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from this disorder since they can also look into different treatment options and
discuss them with their physicians. For many, integrating psychological-based
methods into their treatment plan could make all the difference for both their
physical and mental health.
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